OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
3
Results
Show all
Save search
Copy query
Show results for
Unknown
(3)
Publication Date
Release Date
2025
(1)
2021
(1)
2016
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial.
Not available
S-EPMC6863151
|
biostudies-literature
Cite
Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial.
Not available
S-EPMC8580377
|
biostudies-literature
Cite
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer.
Not available
S-EPMC12819402
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
